| |
| |
|
| Insider
Information: |
Jaen Juan C. |
| Relationship: |
President |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
371,475 |
|
|
Indirect Shares
|
1,188,233 |
|
|
| Direct
Value |
$7,118,913 |
|
|
|
Indirect Value
|
$19,344,433 |
|
|
| Total
Shares |
1,559,708 |
|
|
| Total
Value |
$26,463,346 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -71.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-03-08 |
4 |
AS |
$13.98 |
$29,284 |
D/D |
(2,095) |
30,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-10-01 |
4 |
AS |
$11.98 |
$25,157 |
D/D |
(2,100) |
60,833 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-06-16 |
4 |
S |
$24.13 |
$52,707 |
D/D |
(2,182) |
200,961 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-06-16 |
4 |
S |
$20.72 |
$48,340 |
D/D |
(2,333) |
212,574 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-06-17 |
4 |
S |
$21.71 |
$56,116 |
D/D |
(2,537) |
210,037 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2018-08-10 |
4 |
B |
$11.94 |
$30,796 |
I/I |
2,579 |
2,741,081 |
2.66 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-06-17 |
4 |
S |
$23.68 |
$63,344 |
D/D |
(2,675) |
198,286 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-24 |
4 |
AS |
$11.96 |
$32,358 |
D/D |
(2,705) |
70,634 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-28 |
4 |
AS |
$11.35 |
$30,851 |
D/D |
(2,710) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-28 |
4 |
OE |
$4.30 |
$11,653 |
D/D |
2,710 |
53,928 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-03-05 |
4 |
AS |
$13.97 |
$41,209 |
D/D |
(2,950) |
37,042 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2018-08-13 |
4 |
B |
$11.77 |
$37,168 |
I/I |
3,159 |
2,744,240 |
2.66 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-31 |
4 |
AS |
$11.45 |
$37,752 |
D/D |
(3,280) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-31 |
4 |
OE |
$4.30 |
$14,104 |
D/D |
3,280 |
54,600 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-12 |
4 |
OE |
$4.30 |
$14,212 |
D/D |
3,305 |
56,305 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-12 |
4 |
AS |
$11.35 |
$37,512 |
D/D |
(3,305) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-04 |
4 |
AS |
$11.67 |
$45,294 |
D/D |
(3,875) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-04 |
4 |
OE |
$4.30 |
$16,663 |
D/D |
3,875 |
56,100 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• – – |
2024-02-26 |
4 |
AS |
$20.06 |
$78,234 |
I/I |
(3,900) |
1,211,365 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-03-06 |
4 |
AS |
$13.97 |
$59,329 |
D/D |
(4,247) |
32,795 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2018-08-09 |
4 |
B |
$11.93 |
$50,855 |
I/I |
4,262 |
2,738,502 |
2.66 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-12-16 |
4 |
S |
$30.66 |
$136,407 |
D/D |
(4,436) |
218,258 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2023-06-16 |
4 |
D |
$19.35 |
$93,267 |
D/D |
(4,820) |
313,862 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-29 |
4 |
AS |
$11.45 |
$56,013 |
D/D |
(4,892) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-29 |
4 |
OE |
$4.30 |
$21,036 |
D/D |
4,892 |
57,892 |
0 |
- |
|
92 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
